D. José María Fernández Sousa-Faro, Ph.D. Executive Chairman.

Mr. José María Fernández Sousa-Faro
Degree in Chemistry (1967) and a PhD in Biochemistry (1971) from Universidad Complutense, Madrid. Between 1971 and 1979, he was tenured professor and subsequently held the Chair of Biochemistry at the University of Santiago de Compostela.

MBA from IESE (Universidad de Navarra), Madrid.

He received an Honorary Doctorate from Universidad Antonio de Nebrija and was awarded Spain’s National Biotechnology Prize, both in 2009.

Professional career 
Between 1967 and 1979, he also worked at the following institutions: Institut für Physikalische Chemie at the University of Basel (Switzerland), Department of Molecular Biology at Washington University in Saint Louis, Missouri (USA), and L’Institut de Biologie Physico-Chimique at the Fondation Edmond de Rothschild in Paris, France, ICI Pharmaceuticals Division, Alderley Edge research labs and Shell (Sittingbourne research labs).

He has over 100 academic publications and patents in the fields of biochemistry, molecular biology, and anti-infective and anti-tumor drugs.

Between 1979 and 1985, Mr. Fernández Sousa-Faro was Research Director at Antibióticos S.A. He has been a member of the Board of the following companies: Antibióticos S.A., ICI-Farma S.A., Transportes Ferroviarios Especiales S.A. (Transfesa); Pescanova S.A.; Cooper Zeltia S.A.; Biolys S.A.; ICI-Zeltia S.A.; Penibérica S.A.; Banco Guipuzcoano S.A. and Zeltia S.A.

Current occupation 
Chairman of the Board of Directors of Pharma Mar S.A.

Chairman of the Board of Directors of Genomica S.A. and Sylentis, S.A.; Director of Zelnova Zeltia S.A. (on behalf of Pharma Mar S.A.)

Other positions 
Chairman of Fundación Bankinter para la Innovación.

D. Pedro Fernández Puentes. Executive Vice-Chairman.

Mr. Pedro Fernández Puentes
Degree in Chemistry from the University of Santiago de Compostela.

Professional career 
Between 1965 and 1971, he worked as Head of the new product development lab at Cooper Zeltia, S.A., and became Chairman of that company until it was demerged into Cooper Zeltia Veterinaria, S.A. and Consumo Zeltia S.A. (now, Zelnova Zeltia S.A.)

Chairman of Xylazel, S.A. from 1995 to 1997.

Member of the Board of Directors of ICI Farma S.A., ICI-Zeltia S.A., Corporación Noroeste S.A. and their main subsidiaries for approximately 20 years; Director of Zeltia S.A. from 1971 onwards.

Current occupation 
Chairman of Zelnova Zeltia S.A.
Director and Vice-Chairman of Pharma Mar S.A.

ROSP CORUNNA PARTICIPACIONES EMPRESARIALES, S.L. (represented by D. José Leyte Verdejo). Proprietary director

Degree in Law and Business from Comillas Pontifical University (ICADE).

Professional career 
After graduation, he worked for four years at Arthur Anderson Asesores Legales y Tributarios. He then joined Barclays Banks and was head of Deutsche Bank’s Private Banking department for Galicia and Asturias. Before taking his current position, he headed Caixa Galicia’s Private Banking division.

Current occupation 
Since 2000, he has been the chief executive of ROSP CORUNNA PARTICIPACIONES EMPRESARIALES, S.L., the family office of the late Rosalía Mera and now of her daughter, Sandra Ortega. Mr. Leyte Verdejo also teaches post-graduate courses at a number of academic institutions.

He was formerly a director of Zeltia S.A. and is currently a member of the Board of Directors of Pharma Mar on behalf of ROSP CORUNNA PARTICIPACIONES EMPRESARIALES, S.L.

Dña. Ana Palacio del Valle de Lersundi.
Independent director

Mrs. Ana Palacio del Valle de Lersundi
Degrees in Law, Sociology and Political Science (Special end of degree award). She is Honorary Doctorate from Georgetown University and in 2016 she has been awarded the O’Connor Justice Prize.

Professional career
She is an attorney specialized in international and European Union law, arbitration and mediation, and founder of the Palacio y Asociados Law firm.

Member of the European Parliament, where she chaired the Legal Affairs and Internal Market Committee, the Justice and Home Affairs Committee and the Conference of Committee Chairs (1994-2002).

Spain’s Minister of Foreign Affairs from 2002 to 2004, Member of the Spanish Parliament in its VIII Legislature, timeframe in which she chaired the Joint Congress of Deputies and Senate Commission for the European Union (2004-2006).

Vice-President and General Counsel of the World Bank Group (2006-2008).

General Secretary of the International Centre for the Settlement of Investment Disputes (ICSID) (2006-2008).

Executive Vice-President in charge of International Department of AREVA (2008-2009).

In March 2012, she was appointed an Elective Member of Spain’s Council of State, a position that she holds at present.

Other Board of Directors
Independent Coordinating Director of Enagas, S.A.

Director of AEE Power

Other positions
Advisory Boards of INVESTCORP and OCP

She sits on the Boards of a number of research centers and public institutions, including:

•    Energy Future initiative
•    MD Anderson Cancer Center
•    Atlantic Council (USA)
•    Conseil d’Orientation et de Réflexion de I’Assurance (CORA)

In Spain, she is a member of the Scientific Board of Instituto Elcano and a trustee of Fundación para el Análisis y los Estudios Sociales (FAES), and member of the Governing Council of Instituto de Empresa.

She has been visiting professor of the Edmund E. Walsh School of Foreign Service at Georgetown University since 2014.

JEFPO, S.L.(represented by D. José Félix Pérez-Orive Carceller). Director (Other external)

JEFPO, S.L. (represented by Mr. José Félix Pérez-Orive Carceller)
Degree in Pharmacy from the University of Navarra and degree in Law; he obtained an MBA from IESE (Barcelona) in 1971.

Professional career 
He was manager of Antibióticos, S.A. in the USA from 1979 to 1984, and General Manager in Spain from 1984 to 1987.

He has been a director of over thirty companies and given over 100 lectures to major institutions.

He was a member of the Board of Directors of Zeltia S.A. from June 1990 onwards.

Current occupation 
Since 1987, he has been Chairman of Pérez Orive & Asociados, a company specialized in mergers and acquisitions.

Director of Pharma Mar, S.A.

Vice-Chairman of Xylazel, S.A., Director of Zelnova Zeltia S.A. and Genomica S.A., companies belong to Pharma Mar Group.

D. Jaime Zurita Sáenz de Navarrete. Independent director

Mr. Jaime Zurita Sáenz de Navarrete

Professional career
PhD in Law. Professor of Mercantile Law.

Current occupation 
Practising lawyer.

D.ª Montserrat Andrade Detrell. Proprietary director

Mrs. Montserrat Andrade Detrell
She holds a degree in Biology (1975) and a degree in Medicine (1983) and a diploma in Family and Community Medicine from Universidad Complutense, Madrid. She obtained a Master’s degree in Breast pathology from the University of Strasbourg, France (1991), a postgraduate diploma in Mammary Pathology from the University of Barcelona (1992), and a Master’s degree in that same field one year later; in 1996, she qualified as a specialist in Medicine of the Breast and Mammary Pathology from Universidad Complutense, Madrid.

Additionally, she is certified to supervise X-ray facilities for medical diagnostics by the Centro de Investigaciones Energéticas y Medioambientales y Tecnológicas attached to the Spanish Ministry of Industry and Energy (1991). She completed her internship at Hospital Universitario San Carlos in Madrid (1985–1988)

PhD from Universidad San Carlos (Madrid), and her degree dissertation at Universidad Complutense was granted honours.

She was Head of Institutional Relations at Zeltia S.A. from 2007 to 2012.

Current occupation 
She is currently member of the Board of Directors of Pharma Mar, S.A.

EDUARDO SERRA Y ASOCIADOS, S.L. (represented by Mr. Eduardo Serra Rexach). Independent director

EDUARDO SERRA Y ASOCIADOS, S.L. (represented by Mr. Eduardo Serra Rexach)
Degree in Law from Universidad Complutense (Madrid) and passed the exams to enter the Spanish civil service as a lawyer with the highest marks of that year.

Professional career 
He has held the following positions in the public sector: Chief of Staff to the Minister of Industry and Energy (1977-1979); General Secretary and Board Secretary of Spain’s National Industry Institute (INI) (1979-1982); Director of Banco del Crédito Industrial (1979-1982); Director of Butano (1979-1982); Vice-Chairman of Astilleros Españoles (1979-1982) and Chairman of Auxina (1979-1982); Under-Secretary of Defence (1982-1984); Secretary of State for Defence (1984-1987); Director of Instituto Nacional de Industria (1984-1987) and of Instituto Nacional de Hidrocarburos (INH) (1984-1987).

Spain’s Minister of Defence from 1996 to 2000.

In the private sector, from 1987 to 1996 he was Chairman of Telettra España, Vice-Chairman and subsequently Chairman of Cubiertas Mzov, Chairman of Peugeot-Talbot España, and Chairman of Airtel. From 2000 to 2006, he was Chairman of UBS España. He was Director of Zeltia, S.A.

He was also formerly Vice Chairman and Chairman of Instituto de Cuestiones Internacionales y Política Exterior (INCIPE) (1989-1996), Chairman of the Board of Trustees of Museo del Prado (2000-2004) and founding Chairman of Real Instituto Elcano (2001-2005) and Chairman of Fundación EVERIS (2005-2014).

Current occupation

Vice-Chairman of EVERIS.

Chairman of the consulting firm Eduardo Serra y Asociados, S.L.

Board member of Pharma Mar S.A.

Acts as director, advisor or trustee in numerous non-profit entities.

Chairman of Park Row Digital S.L.

D. Carlos Solchaga Catalán. Independent director

Mr. Carlos Solchaga Catalán
Degree in Economics and Business from Universidad Complutense (Madrid), in 1966 and completed post-graduate studies at the Alfred P. Sloan School of Business at Massachusetts Institute of Technology (MIT) in 1971.

Professional career 
He began his career at the Bank of Spain, then transferred to the Instituto Nacional de Industria (INI) and subsequently to Banco de Vizcaya, where he was Director of Research and Advisor to the Chairman.

Spain’s Minister of Industry and Energy (1982-1985) and later Minister of Economy and Finance (1985-1993). Between 1991 and 1993, he was Chairman of the Internal Committee of the International Monetary Fund (IMF). He was a member of the Spanish parliament from 1980 to 1994, and headed the socialist parliamentary group between 1993 and 1994.

Current occupation  
Chairman of Solchaga Recio & Asociados.

Honorary President of Fundación Euroamérica.

Vice-Chairman of the Board of Trustees of Museo Centro de Arte Reina Sofía.

Chairman of Fundación Arquitectura y Sociedad

Chairman of the Advisory Board of Bufete Roca & Junyent.

Member of the Scientific Committee of Real Instituto Elcano.

Other Board of Directors

Director of Cie Automotive, S.A.

Senior Management

The Senior Management of PharmaMar is entrusted with the task of defining and implementing the Company´s strategy.

Oncology pipeline

PharmaMar develops and commercializes YONDELIS® in Europe and has three clinical-stage drug candidates under development for several types of solid and hematological cancers, Aplidin ®, Lurbinectedin, and PM184.


If you need information about the company, our clinical trials, corporate images or multimedia, visit our newsroom